Share on StockTwits

Amsurg Corp (NASDAQ:AMSG) was upgraded by equities research analysts at Robert W. Baird from a “neutral” rating to an “outperform” rating in a research note issued to investors on Friday, reports. The firm currently has a $55.00 target price on the stock, up from their previous target price of $44.00. Robert W. Baird’s price objective would suggest a potential upside of 20.09% from the company’s current price.

A number of other analysts have also recently weighed in on AMSG. Analysts at Raymond James upgraded shares of Amsurg Corp from a “market perform” rating to a “strong-buy” rating in a research note on Friday, May 30th. They now have a $60.00 price target on the stock. Separately, analysts at Deutsche Bank upgraded shares of Amsurg Corp from a “hold” rating to a “buy” rating in a research note on Thursday, May 29th. They now have a $56.00 price target on the stock, up previously from $47.50. Finally, analysts at Barclays cut their price target on shares of Amsurg Corp from $50.00 to $49.00 in a research note on Thursday, April 24th. They now have an “equal weight” rating on the stock. Four research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $52.75.

Amsurg Corp (NASDAQ:AMSG) traded down 1.51% on Friday, hitting $45.11. The stock had a trading volume of 6,147,753 shares. Amsurg Corp has a 52-week low of $35.06 and a 52-week high of $52.81. The stock’s 50-day moving average is $46.17 and its 200-day moving average is $45.1. The company has a market cap of $1.434 billion and a price-to-earnings ratio of 20.36.

Amsurg Corp (NASDAQ:AMSG) last announced its earnings results on Tuesday, April 22nd. The company reported $0.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by $0.02. The company had revenue of $263.11 million for the quarter, compared to the consensus estimate of $272.09 million. During the same quarter in the previous year, the company posted $0.52 earnings per share. The company’s revenue for the quarter was up 1.9% on a year-over-year basis. Analysts expect that Amsurg Corp will post $2.44 EPS for the current fiscal year.

AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (NASDAQ:AMSG) in the United States.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.